Veterinary Medicines

Adedri-kel (100 +50 + 5), oplossing voor injectie

Not authorised
  • Colecalciferol
  • ALPHA-TOCOPHEROL
  • DL-ALPHA TOCOPHEROL ACETATE
Download as PDF

Product identification

Medicine name:
Adedri-kel (100 +50 + 5), oplossing voor injectie
Active substance:
  • Colecalciferol
  • ALPHA-TOCOPHEROL
  • DL-ALPHA TOCOPHEROL ACETATE
Target species:
  • Cattle
  • Goat (adult female)
  • Sheep
  • Cattle (calf)
  • Sheep (lamb)
  • Horse
  • Pig
  • Pig (piglet)
  • Horse (foal)
  • Cattle (bull)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Colecalciferol
    50000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • ALPHA-TOCOPHEROL
    100000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • DL-ALPHA TOCOPHEROL ACETATE
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        5
        day
      • Meat and offal
        259
        day
    • Goat (adult female)
      • Milk
        5
        day
      • Meat and offal
        194
        day
    • Sheep
      • Milk
        5
        day
      • Meat and offal
        194
        day
    • Cattle (calf)
      • Meat and offal
        259
        day
    • Sheep (lamb)
      • Meat and offal
        194
        day
    • Horse
      • Meat and offal
        222
        day
    • Pig
      • Meat and offal
        231
        day
    • Pig (piglet)
      • Meat and offal
        231
        day
    • Horse (foal)
      • Meat and offal
        222
        day
    • Cattle (bull)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11BA
Legal status of supply:
  • Medicinal product not subject to medical prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Kela - Kempisch Laboratorium - Kela Laboratoria
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 4695
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 23/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."